Stay updated on APX005M + Pembrolizumab in Metastatic Melanoma Clinical Trial

Sign up to get notified when there's something new on the APX005M + Pembrolizumab in Metastatic Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the APX005M + Pembrolizumab in Metastatic Melanoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A banner announces NIH website updates and explains that some federal agencies are using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) during the transition.
    Difference
    0.4%
    Check dated 2026-10-25T20:16:39.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The site footer’s revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T22:44:13.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer now identifies the ClinicalTrials.gov site revision as v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-11T22:51:44.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    The history now shows an updated revision entry for v3.7.0, replacing the previous v3.6.6, indicating an update to the study record.
    Difference
    0.1%
    Check dated 2026-09-20T22:49:29.000Z thumbnail image
  5. Check
    59 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.5 to v3.6.6, signaling a small system update to the history page without altering study information.
    Difference
    0.1%
    Check dated 2026-08-30T21:58:46.000Z thumbnail image
  6. Check
    81 days ago
    Change Detected
    Summary
    The history section gains a new Revision: v3.6.5 entry while removing the previous Revision: v3.6.4, updating the page's version-tracking metadata.
    Difference
    0.1%
    Check dated 2026-08-09T11:07:42.000Z thumbnail image

Stay in the know with updates to APX005M + Pembrolizumab in Metastatic Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the APX005M + Pembrolizumab in Metastatic Melanoma Clinical Trial page.